Willow Biosciences Inc. has undertaken two initiatives to improve the understanding of cannabigerol (CBG), the company’s first commercial cannabinoid slated for production in the first quarter of 2021.

Founded by Chris Hetherington, Peels has secured a $4 million investment from KarpReilly, LLC, a Greenwich, Connecticut-based private investment firm.

Treehouse will serve as a center of scientific excellence and product development for Next Frontier Brands and will manufacture the company's growing portfolio of hemp-based wellness products.

Charlotte's Web Holdings, Inc.’s CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences are collaborating to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.

This THC-free cannabinol (CBN) isolate is refined and purified through multi-phase distillation.

New research, published in the “Journal of Agricultural and Food Chemistry,” suggests a product’s matrix can impact a lab’s ability to precisely test for cannabinoid content.

Matthew Anderson, CEO of Vanguard Scientific, offered insights on the challenges cannabis ingredient suppliers and buyers face from seed to sale during Cannabis Products Exchange, held virtually July 30-31.

Radient Technologies Inc.'s Board of Directors is conducting a strategic review of the company’s operations, including management changes.